Variant report
Variant | esv3399155 |
---|---|
Chromosome Location | chr5:147289018-147289590 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
C5orf46 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576949630 | chr5:147289062-147289063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs59755025 | chr5:147289063-147289064 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs557701168 | chr5:147289103-147289104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs60307992 | chr5:147289151-147289152 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs537122447 | chr5:147289172-147289173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371401229 | chr5:147289180-147289181 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs71580460 | chr5:147289195-147289196 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573871791 | chr5:147289199-147289200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536408352 | chr5:147289201-147289202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556006984 | chr5:147289202-147289203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552898678 | chr5:147289210-147289211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111512468 | chr5:147289329-147289330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577842993 | chr5:147289337-147289338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143008723 | chr5:147289339-147289340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78105895 | chr5:147289421-147289422 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs80135206 | chr5:147289429-147289430 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs114976656 | chr5:147289433-147289434 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs561003600 | chr5:147289439-147289440 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs193008318 | chr5:147289453-147289454 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs547142167 | chr5:147289473-147289474 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs111882220 | chr5:147289544-147289545 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112347387 | chr5:147289545-147289546 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538290554 | chr5:147289553-147289554 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532824730 | chr5:147289579-147289580 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Hyperekplexia | 16941485 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Crohn''s disease | 20877625 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:147284200-147291000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr5:147286600-147289400 | Weak transcription | Gastric | stomach |
3 | chr5:147286600-147291800 | Weak transcription | Aorta | Aorta |
4 | chr5:147286800-147289400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr5:147286800-147291000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
6 | chr5:147286800-147291000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
7 | chr5:147286800-147293000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr5:147286800-147293000 | Weak transcription | HMEC | breast |
9 | chr5:147289000-147289800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
10 | chr5:147289000-147289800 | Enhancers | Left Ventricle | heart |
11 | chr5:147289000-147289800 | Enhancers | Pancreas | Pancrea |
12 | chr5:147289000-147291400 | Enhancers | Fetal Heart | heart |
13 | chr5:147289400-147289600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr5:147289400-147289800 | Enhancers | Gastric | stomach |